ELIGARD 22.5 mg, powder and solvent for solution for injection syringe
Active ingredients: Leuprolide acetate, LEUPRORÉLINE
Commercialized according to BDPMDispensing in France: Prescription only
Powder and solvent for solution for injectionsyringesous-cutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ELIGARD 22,5 mg, poudre et solvant pour solution injectable
- Pharmaceutical form
- poudre et solvant pour solution injectable
- Route of administration
- sous-cutanée
- Presentation description
- 1 seringue préremplie polycyclooléfine de poudre pré-connectée à 1 seringue préremplie polypropylène de solvant
- Marketing authorisation holder
- RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA (ITALIE)
- Reimbursement according to BDPM
- 100%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 13 Feb 2006
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60639255CIP73669092CIP133400936690929Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| LEUPRORÉLINEpoudre | 20,87 mg · une seringue préremplie de poudre pour solution injectable | FT |
| ACÉTATE DE LEUPRORÉLINEpoudre | 22,5 mg · une seringue préremplie de poudre pour solution injectable | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.